THE DUBERSTEIN GROUP INC.

Lobbying for PHRMA INC. · Represents leading research-based pharmaceutical and biotechnology companies in the US

Filing 1st Quarter - Termination

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $25,000.00 income · posted Apr 21, 2025

Lobbying activity 1

Health Issues

PBM issues Issues related to the 340B program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.